home.social

#neuroscienceresearch — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #neuroscienceresearch, aggregated by home.social.

fetched live
  1. DATE: September 28, 2026 at 10:00AM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: Neuroscientists shed light on how the brain juggles talking and listening during real conversation

    URL: psypost.org/how-the-brain-jugg

    When humans engage in a conversation, the brain must seamlessly process both the words they want to say and the sentences they are hearing. A new study reveals that the brain uses shared neural codes for speaking and listening during short verbal exchanges, but relies on distinct timing networks to process longer, overarching ideas. These findings, published in Nature Human Behaviour, help map how the brain navigates the back-and-forth demands of natural social interaction.

    Conversation is a highly dynamic activity that requires people to understand context, anticipate responses, and build a cohesive narrative together. To do this, the human brain must integrate language across multiple timescales. This ranges from the immediate processing of individual words to the broader comprehension of entire paragraphs and concepts.

    For decades, researchers have studied how the brain processes language by having participants listen to isolated sentences or read long narratives. These past experiments established that the brain organizes language hierarchically. However, it was not entirely known how the brain handles the two-way street of spontaneous, real-time conversation.

    Neuroscientists sought to determine whether the brain uses the exact same linguistic representations for generating speech and comprehending speech, or if it keeps those processes separated. A research team led by Masahiro Yamashita and Shinji Nishimoto at Osaka University and the National Institute of Information and Communications Technology in Japan set out to answer this question. They designed a study to map out how brain activity shifts depending on whether a person is talking or listening, and how much previous context they are factoring in.

    The researchers recruited eight native Japanese speakers for a small study involving brain imaging. Each participant lay inside a functional magnetic resonance imaging scanner, a machine that tracks blood flow in the brain to measure neural activity. While inside the scanner, the participants engaged in unscripted, natural conversations with an experimenter through a microphone and earphones. They discussed casual topics, such as their favorite classes and personal introductions, for roughly three hours each.

    To translate the messy, spontaneous nature of human speech into a format the researchers could analyze, they turned to a large language model. This artificial intelligence tool, based on the GPT architecture, was trained to predict language patterns by processing massive amounts of text. The researchers fed the transcripts of the participants’ conversations into the artificial intelligence to extract mathematical representations of the text’s meaning, known as contextual embeddings. They did this for different lengths of time, analyzing context windows that lasted anywhere from one second to thirty-two seconds.

    The team then built computer models to predict the brain activity of the participants based on the artificial intelligence’s mathematical breakdown of the conversations. They first tested a model that treated speaking and listening as one shared pool of meaning. The results showed that when looking at short timescales of one to four seconds, the brain shares its linguistic representations regardless of whether a person is talking or listening. The neural codes used for formulating a quick thought and hearing a brief sentence overlapped in the prefrontal, temporal, and parietal cortices.

    However, the researchers found a different pattern when examining longer stretches of conversation. When looking at context windows of sixteen to thirty-two seconds, the shared representations scattered across the brain. The patterns varied widely from person to person, occasionally reaching regions associated with guessing the thoughts of others and recalling memories. This suggests that while the brain uses a universal system to process immediate words, individuals use personalized strategies to integrate overarching social context and long-term conversation history.

    Next, the researchers isolated the brain activity uniquely tied to just speaking or just listening. They discovered an opposing timescale preference for each action. The brain areas dedicated to producing speech were most active when processing short-term context. Conversely, the brain areas dedicated to understanding the experimenter’s speech were most active when processing long-term context spanning multiple sentences.

    This division aligns with the specific demands of each task. Producing speech requires a person to react quickly to what the other person just said, planning words and sentence structures on the fly. Listening requires a person to hold onto information over time to build a complete mental model of what their conversational partner means.

    The researchers also looked for brain regions that responded robustly to both speaking and listening, but in completely independent ways. They identified specific bimodal zones that peaked in activity only when factoring in longer context lengths of eight seconds or more. These areas encoded meaning for both tasks but did not share the exact same neural patterns, pointing to specialized regions that help individuals separate their own perspectives from those of their conversation partners. To navigate a dialogue, the brain must keep track of who knows what, and these bimodal zones likely support that cognitive juggling.

    Finally, the team used a statistical technique to break down the specific types of words that drove the strongest brain responses at short timescales. They found that conversational fillers and short confirmations, such as “yeah” or “uh,” evoked distinct neural patterns. These tiny words require very little cognitive effort to say, but they act as social glue to maintain the flow of dialogue. The brain appears to have dedicated neural tuning for these interactive words, separating them from highly logical or factual statements.

    Because this was a small study involving only eight people, the findings represent a narrow slice of the population. The researchers noted that they did not use functional localizer tasks, which are preliminary tests used to outline established brain networks, such as the regions responsible for mentalizing what other people are thinking. Without these preliminary tests, the team could not definitively map their results onto precisely defined cognitive networks. Future research with larger groups and additional mapping techniques will be needed to confirm exactly which distinct brain networks manage these conversational timelines.

    The study, “Conversational content is organized across multiple timescales in the brain,” was authored by Masahiro Yamashita, Rieko Kubo, and Shinji Nishimoto.

    URL: psypost.org/how-the-brain-jugg

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #BrainSpeechTiming #ConversationNeuroscience #LanguageProcessing #SpeakingVsListening #NeuralCodes #ContextWindow #BimodalRegions #SocialCommunication #GPTEmbeddings #NeuroscienceResearch

  2. DATE: September 18, 2026 at 12:00PM
    SOURCE: PSYPOST.ORG

    ** Research quality varies widely from fantastic to small exploratory studies. Please check research methods when conclusions are very important to you. **
    -------------------------------------------------

    TITLE: Lithium supplementation does not slow cognitive decline in Alzheimer’s disease, meta-analysis finds

    URL: psypost.org/lithium-supplement

    A recent meta-analysis evaluating the cognitive effects of lithium supplementation in older adults found that the mineral does not slow cognitive decline in individuals with Alzheimer’s disease or mild cognitive impairment. The research provides evidence that commonly prescribed forms of lithium are not effective at preserving memory and thinking skills in this population. The findings were published in the Neuroscience and Biobehavioral Reviews.

    Alzheimer’s disease is a progressive condition of the brain where brain cells gradually degrade and die, leading to worsening memory, confusion, and an inability to perform daily tasks. The disease is characterized by the accumulation of harmful proteins in the brain, namely amyloid-beta plaques and tau tangles, which disrupt cell communication and cause inflammation. Before a person develops full Alzheimer’s disease, they often experience mild cognitive impairment, an intermediate stage of memory loss that is noticeable but does not completely disrupt everyday life. Finding treatments that can halt or slow this progression from early memory loss to severe dementia is a major priority in medical science.

    One substance that has attracted attention as a potential treatment is lithium. Lithium is a naturally occurring mineral that is most commonly formulated as a medication, such as lithium carbonate, to stabilize mood in people with bipolar disorder. In recent years, laboratory experiments have suggested that lithium might also protect brain cells from the damage seen in Alzheimer’s disease by blocking specific enzymes that lead to protein buildup.

    A series of small clinical trials and earlier pooled reviews yielded mixed evidence on whether lithium can actually slow cognitive decline in humans. For example, a 2009 clinical trial investigated whether a short course of lithium could alter disease markers and slow mental decline in patients with Alzheimer’s, but it found no major benefit.

    A few years later, a 2011 clinical trial indicated that long-term, low-dose lithium treatment helped stabilize memory and thinking in patients with mild cognitive impairment. Trying to make sense of these varying outcomes, a 2015 meta-analysis combined the results of these early clinical trials, yielding intriguing but still inconclusive evidence about the mineral’s protective effects.

    This conflicting background set the stage for an updated analysis of lithium’s therapeutic value in Alzheimer’s disease. The research team, led by Taro Kishi of the Fujita Health University School of Medicine, wanted to incorporate the most recent clinical trials into a single, comprehensive statistical model to see if lithium offers any reliable cognitive benefits for people with mild cognitive impairment and Alzheimer’s disease.

    To explore this question, the scientists utilized a meta-analysis, which is a statistical method that pools data from multiple independent studies to identify broader trends that a single study might miss. The researchers searched major scientific databases for randomized, placebo-controlled trials that tested lithium supplementation in individuals diagnosed with mild cognitive impairment or Alzheimer’s disease. In these types of trials, one group of patients receives the active medication while another receives an inactive dummy pill, allowing researchers to isolate the effects of the drug.

    The final analysis included six clinical trials with a total of 435 participants. Two of the trials focused exclusively on patients with mild cognitive impairment, while the others included patients with various stages of Alzheimer’s disease. The length of the studies varied, with some tracking patients for just 10 weeks and others following them for up to two years. The types of lithium used in these trials were mostly inorganic salts, predominantly lithium carbonate, though some used lithium sulfate or lithium gluconate.

    To measure cognitive changes, the original studies used standardized tests such as the Alzheimer’s Disease Assessment Scale-Cognitive Subscale and the Mini-Mental State Examination. These tools are questionnaires and tasks designed to evaluate memory, language, attention, and basic problem-solving skills. The research team compared the cognitive test scores of the patients who took lithium with those who took a placebo to determine if the mineral slowed their rate of mental decline.

    The researchers found that lithium supplementation was not better than a placebo at preserving cognitive function. When combining the data from all six studies, the difference in cognitive test scores between the lithium group and the placebo group was not statistically significant. The patients taking lithium experienced a similar rate of memory and thinking decline as those who did not receive the treatment.

    The team also looked at secondary outcomes, including behavioral symptoms like agitation and aggression, which are common in advancing Alzheimer’s disease. Once again, the results were not statistically significant; lithium did not improve behavioral symptoms better than a placebo. Similarly, the rates of people dropping out of the studies or experiencing adverse side effects were roughly equal between the lithium and placebo groups.

    To ensure they were not missing specific scenarios where lithium might work, the scientists performed several subgroup analyses. They checked whether the results differed depending on the patient’s diagnosis, the length of the study, the dose of lithium, or the specific formulation used. In all of these categories, lithium consistently failed to show an advantage over the placebo.

    These findings are in line with research covered by PsyPost in May 2026, which found that lithium chloride treatment reduced harmful protein activity and altered brain signaling. However, the new meta-analysis evaluated clinical cognitive outcomes in human patients rather than molecular and cellular changes in laboratory cell cultures.

    The results also offer interesting context for another study covered by PsyPost in September 2025. That study, which used mouse models rather than human clinical trials, found that treatment with a specific organic salt called lithium orotate prevented harmful protein accumulation and improved memory. While those animal and cellular studies suggest lithium has biological effects on Alzheimer’s mechanisms, the new study indicates that the specific inorganic lithium salts commonly used in human clinical trials, such as lithium carbonate, do not translate into measurable cognitive benefits for human patients.

    As with all research, there are some caveats to consider. The meta-analysis was based on a relatively small number of studies and a modest total of 435 participants, which limits the statistical power of the analysis. A larger pool of data might be needed to detect very subtle effects. There are also a few things to keep in mind regarding the participants themselves. In the older trials, patients with mild cognitive impairment were diagnosed based on clinical symptoms rather than modern biological markers like brain scans or spinal fluid tests. This means some participants might have had memory issues caused by conditions other than early Alzheimer’s disease.

    Additionally, the patients in these trials were often taking standard anti-dementia medications alongside the lithium or placebo. The types and combinations of these medications varied across the studies, which might have influenced the outcomes. Finally, the analysis focused heavily on inorganic lithium salts like lithium carbonate and lithium sulfate. Some researchers suggest that organic salts like lithium orotate might enter brain cells more efficiently and with fewer side effects, but human clinical trials testing lithium orotate for Alzheimer’s disease are currently lacking.

    The study, “Lithium for Alzheimer’s disease: Insights from a meta-analysis,” was authored by Taro Kishi, Shinji Matsunaga, Youichi Saito, and Nakao Iwata.

    URL: psypost.org/lithium-supplement

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #LithiumAlzheimersNo Benefit #AlzheimersDisease #CognitiveDecline #MildCognitiveImpairment #LithiumSupplementation #NeuroscienceResearch #ClinicalTrials #MetaAnalysis #AlzheimersTreatment #BrainHealth

  3. DATE: September 15, 2026 at 10:28AM
    SOURCE: SCIENCE DAILY MIND-BRAIN FEED

    TITLE: Scientists discover a major brain shift between ages 50 and 75

    URL: sciencedaily.com/releases/2026

    Scientists have uncovered sweeping changes in how the human brain controls and organizes its genome beginning in midlife, offering new clues to why aging sharply increases the risk of Alzheimer’s and other neurodegenerative diseases. One of the biggest shifts occurred between about ages 50 and 75, when many of the brain’s original immune cells declined and were replaced by cells with more inflammatory characteristics. Researchers also found weakening of cells that help maintain the blood-brain barrier, along with widespread deterioration in the genome’s three-dimensional organization.

    URL: sciencedaily.com/releases/2026

    -------------------------------------------------

    Private, vetted email list for mental health professionals: clinicians-exchange.org

    Unofficial Psychology Today Xitter to toot feed at Psych Today Unofficial Bot @PTUnofficialBot

    -------------------------------------------------

    #psychology #counseling #socialwork #psychotherapy @psychotherapist @psychotherapists @psychology @socialpsych @socialwork @psychiatry #mentalhealth #psychiatry #healthcare #depression #psychotherapist #BrainShift #AgingResearch #MidlifeScience #AlzheimersAwareness #Neurodegeneration #ImmuneCells #BloodBrainBarrier #GenomeOrganization #AgingBrain #NeuroscienceResearch

  4. @elduvelle_neuro

    Only few #neuroscience papers with multi animals/humans/ai methods.

    Lab mice models methods are invasive/non-reversible surgeries, diet/drugs restrictions/overdose, optogenetics, etc. Then post recovery therapies, or even euthanized.

    Human methods non-invasive in healthy human patients, or less invasive in few terminally ill human patients.

    Yet still underrated this key question on theoretics methods comparison rationale in multi humans/animals/ai #neuroscienceresearch

    1/2

  5. #CCN2024 keynote In which Prof @NicoleCRust exposes nowadays crossroads blocks in #neuroscience research, subfields, always expanding #neurotech possibles, etc., leading to more route paths incognitos, while still lacking grounded scientific theoretical consensus.

    Ending with future #neuroscienceresearch framework proposal with broader toolsets adoptions, brave new theoretics, openness towards unknown paths....
    Then Q&A with young students expertise audience questions !

    youtu.be/m47qHAJftR4

  6. Join us next Thursday to hear from Dr Hannah Payne (Columbia University’s Zuckerman Mind Brain and Behavior Institute), the second Emerging Neuroscientists Seminar Series of the academic year.

    Dr Payne will discuss spatial representations in the hippocampus, specifically in food-caching birds. Find out more and register: sainsburywellcome.org/web/even

    #SeminarSeries #NeuroscienceResearch #ENSS

  7. Is anyone studying (or know someone who is) a correlation between a decline in auditory processing and the increased use of smartphones? #auditoryprocessing #smartphones #neuroscienceresearch #NeuroScience

  8. Join us next Thursday to hear from Dr @AliceCMo (Columbia’s Zuckerman Mind Brain and Behavior Institute), the first Emerging Neuroscientists Seminar Series speaker of the academic year.

    Find out more about and register: sainsburywellcome.org/web/even

    #SeminarSeries #NeuroscienceResearch #ENSS

Share on Mastodon

Enter the server where you have an account.